- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
PLAY BUTTON
PLAY BUTTON
50 Cards in this Set
- Front
- Back
|
Rb
|
Tumor suppressor
Lost in: retinoblastoma, osteosarcoma |
|
p53
|
Tumor suppressor
Lost in: most human cancers, li fraumeni sro |
|
BRCA1
|
Tumor suppressor
Lost in: breast and ovarian cancer (BRCA2 = only breast) |
|
BRCA2
|
Tumor suppressor
Lost in: only breast CA (BRCA1 = breast & ovarian) |
|
p16
|
Tumor suppressor
Lost in: melanoma |
|
APC
|
Tumor suppressor
Lost in: colorectal |
|
DPC
|
Tumor suppressor
Lost in: Pancreatic Cancer (Mn: Deleted = Pancreatic Ca) |
|
DCC
|
Tumor suppressor
Lost in: Colon Cancer (MN: Deleted = Colon CA) |
|
abl
|
Proto-oncogene Tyrosine Kinase
Mutated In: CML |
|
c-myc
|
Protooncogene Transcription Factor
Mutated in: burkitt's lymphoma |
|
bcl-2
|
Protooncogene Anti-apoptotic Molecule
Mutated in: follicular and undifferentiated lymphomas |
|
erb-B2
|
Protooncogene Tyrosine Kinase
Mutated in: breast, ovarian and gastric carcinomas |
|
ras
|
Protooncogene GTPase
Mutated in: Colon carcinoma |
|
L-myc
|
Protooncogene Transcirption Factor
Mutated in: Lung tumors (L for lung) |
|
N-myc
|
Protooncogene Transcription Factor
Mutated in: Neuroblastoma (N for neuroblastoma) |
|
ret
|
Protooncogene Tyrosine Kianse
Mutated in: MEN 2a & 2b |
|
c-kit
|
Protooncogene Cytokine Receptor
Mutated in: Gastrointestinal Stromal Tumor (GIST) |
|
Down Sro:
Neoplasia Risk |
ALL, AML
|
|
Xeroderma pigmentosa
Neoplasia Risk |
melanoma, basal cell carcinoma and esp squamous cell carcinoma
(same as albinism) |
|
albinism
Neoplasia Risk |
melanoma, basal cell carcinoma and esp squamous cell carcinoma
(same as xeroderma pigmentosa) |
|
Down Sro:
Neoplasia Risk |
ALL, AML
|
|
Xeroderma pigmentosa
Neoplasia Risk |
melanoma, basal cell carcinoma and esp squamous cell carcinoma
(same as albinism) |
|
albinism
Neoplasia Risk |
melanoma, basal cell carcinoma and esp squamous cell carcinoma
(same as xeroderma pigmentosa) |
|
Chronic atrophic gastritis
Neoplasia Risk |
Gastric adenocarcinoma
|
|
pernicious anemia
Neoplasia Risk |
Gastric adenocarcinoma
|
|
tuberous scleorsis
Neoplasia Risk |
astrocytoma, angiomyolipoma, cardiac rhabdomyoma
|
|
actinic keratosis
Neoplasia Risk |
squamous cell carcinoma
|
|
Barrett's eosphagitis
Neoplasia Risk |
esophageal adenocarcinoma
|
|
Plummer Vinson Sro
Neoplasia Risk |
esophageal squamous cell carcinoma
|
|
Cirrhosis
Neoplasia Risk |
hepatocellular carcinoma
|
|
Ulcerative Colitis
Neoplasia Risk |
colonic adenocarcinoma
|
|
Paget's Dz (Bone)
Neoplasia Risk |
osteosarcoma and fibrosarcoma
|
|
Immunodeficiency
Neoplasia Risk |
malignant lymphomas
|
|
AIDS
Neoplasia Risk |
aggressive malignant lymphomas, kapsoi's sarcoma
|
|
Autoimmun Dz's
Neoplasia Risk |
lymphoma
|
|
Acanthrosis Nigricans
Neoplasia Risk |
visceral malignancies (stomach, lung, breast uterus)
|
|
Dysplastic Nevus
Neoplasia Risk |
malignant melanoma
|
|
Radiation
Neoplasia Risk |
Sarcoma, papillary thyroid cancer
|
|
have gone through
|
protooncogenes
tumor suppressors predisposing conditions need to go through tumor markers ongocenic microbes, toxins and paraneopalstic sros cannot find a good list of translcoations. |
|
t(9:22)
|
CML
|
|
t(8;21)
|
AML & ALL
also 15;17 NB: t(10;14) → T cell ALL |
|
t(15;17)
|
AML & ALL
also t(8;21) |
|
t(8;14)
|
Burkitt's Lymphoma
|
|
t(11;14)
|
Mantle Cell Lymphoma
|
|
t(14;18)
|
follicular lymphoma
|
|
t(10;14)
|
T cell ALL
|
|
t(11;22)
|
Ewing Sarcoma
|
|
t(21;21)
|
Prostatic Adenocarcinoma
also t(7;21) and t(17;21) |
|
t(7;21)
|
prostatic adenocarcinoma
also t(21;21) and t(17;21) |
|
t(17;21)
|
prostatic adenocarcinoma
also t(21;21) and t(7;21)) |
